PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $379,034 | -30.5% | 9,817 | -4.2% | 0.00% | -25.0% |
| Q3 2022 | $545,000 | -8.7% | 10,248 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $597,000 | -23.7% | 10,248 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $782,000 | +41.7% | 10,248 | +11.6% | 0.00% | +33.3% |
| Q4 2021 | $552,000 | -73.7% | 9,181 | -85.9% | 0.00% | -84.2% |
| Q4 2016 | $2,096,000 | +23.0% | 64,900 | +30.3% | 0.02% | +11.8% |
| Q3 2016 | $1,704,000 | +1.4% | 49,800 | 0.0% | 0.02% | -10.5% |
| Q2 2016 | $1,680,000 | +51.1% | 49,800 | +137.4% | 0.02% | +26.7% |
| Q1 2016 | $1,112,000 | -83.7% | 20,980 | -76.4% | 0.02% | -81.0% |
| Q4 2015 | $6,819,000 | -20.0% | 88,795 | -57.2% | 0.08% | -20.2% |
| Q3 2015 | $8,522,000 | -41.9% | 207,355 | 0.0% | 0.10% | -36.9% |
| Q2 2015 | $14,664,000 | +57.4% | 207,355 | +97.8% | 0.16% | +61.9% |
| Q1 2015 | $9,315,000 | – | 104,835 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |